Davi Skin 8-K/A Completion of Acquisition or Disposition of Assets

DAVI SKIN, INC. f.k.a.

MW MEDICAL, INC.

PRO FORMA

CONSOLIDATED BALANCE SHEETS

JUNE 30, 2004

(UNAUDITED)

;                                       Historical
;                                 Davi Skin, Inc. fka                                                                                               Pro Forma
;                       Davi Skin, Inc.    MW Medical, Inc.    Consolidated             Pro Forma                    Consolidated
;                       (Unaudited)          (Unaudited)                Total                 Adjustments                         Total
ASSETS
Current assets
Cash	$	590,171		$	-		$	590,171					$	590,171
Stock subscription receivable		8,200			-			8,200						8,200
Total current assets		598,371			-			598,371						598,371
Fixed assets		19,752			-			19,752						19,752
Total assets	$	618,123		$	-		$	618,123					$	618,123
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable and accrued liabilities	$	17,889		$	1,922		$	19,811					$	19,811
Due to related parties		-			200,000			200,000						200,000
Total current liabilities		17,889			201,922			219,811						219,811
Long term debts		-			-			-						-
Total liabilities		17,889			201,922			219,811						219,811
Stockholders' equity
Common stock		9,746			645			10,391						10,391
Additional paid-in capital		763,802			15,656,923			16,420,725			15,656,923	(a)		763,802
Retained earnings (accumulated deficit)		(173,314	)		(15,859,490	)		(16,032,804	)		(15,656,923	)		(375,881)
Total stockholders' equity		600,234			(201,922	)		398,312						398,312
Total liabilities and stockholders' equity	$	618,123		$	-		$	618,123		$	-		$	618,123

(a)     Adjustment to related to reverse-merger transaction

 1

DAVI SKIN, INC. f.k.a.MW MEDICAL, INC.

PRO FORMA

CONSOLIDATED STATEMENTS OF INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2004

(UNAUDITED)

;                                     Historical
;                                                Davi Skin, Inc. fka                                                                            Pro Forma
;                     Davi Skin, Inc.   MW Medical, Inc.   Consolidated          Pro Forma                     Consolidated
;                     (Audited) (a)          (Unaudited )             Total               AdjustmentsTotal
Revenues	$	-		$	-		$	-		$	-			$	-
Operating expenses
Depreciation, depletion and amortization		999			-			999			-				999
Selling, general and adminstrative expenses		173,189			93,686			266,875			(93,686	)	(b)		173,189
Total operating expenses		174,188			93,686			267,874			(93,686	)			174,188
Income from operations		(174,188	)		(93,686	)		(267,874	)		93,686				(174,188)
Other income (expense)
Interest income		874			-			874			-				874
Interest expense		-			(22,327	)		(22,327	)		22,327		(b)		-
Total other income (expense)		874			(22,327	)		(21,453	)		22,327				874
Income before income taxes		(173,314	)		(116,013	)		(289,327	)		116,013				(173,314)
Income taxes		-			-			-			-				-
Net income	$	(173,314	)	$	(116,013	)	$	(289,327	)	$	116,013			$	(173,314)
Earnings per share:
Basic and fully diluted earnings per share														$	(0.02)
Weighted average outstanding shares used in calculation															10,390,667

(a)     Operations related to Davi Skin, Inc. reflects activities from March 21, 2004 (Date of Inception) through June 30, 2004.

(b)     Elimination of operations for the Registrant prior to the reverse merger transaction.

2 

NOTES TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS

On June 21, 2004, the Company completed and closed a Plan of Merger and Reorganization Agreement ("Merger Transaction") with Davi Skin, Inc. ("Davi"), a privately owned company, whereby both parties agreed that a subsidiary of the Company would merge into and with Davi and become a wholly owned subsidiary of the Company. As consideration for this merger transaction, the Company issued 9,745,634 shares of its common stock in exchange for all the outstanding common stock of Davi on a one-for-one share exchange basis. The Agreement further provided for Company’s officers and directors were to resign and the board of directors of Davi would become the board of directors for the Company. This transaction has been accounted for as a quasi-reorganization or reverse merger whereby Davi would be considered the accounting acquirer, and the accounting history of the acquirer would be carried forward as the history for the Company and no goodwill would be recorded. Accordingly, the accompanying financial statements reflect the history of Davi from its date incorporation of March 21, 2004 (incorporated in the State of Nevada). Prior to the Merger Transaction, the Company had 645,033 shares of its common stock outstanding, $1,922 in accounts payable, $200,000 in a note payable to a related party and no assets.

The adjustments to the historical financial statements reflect the effect of the recording of the reverse merger of the Registrant and the previously privately-held Davi. The reported results of operations and financial condition are those of Davi. The adjustments eliminate the results of operations for the Registrant for the periods before the reverse acquisition of the Registrant by Davi, combine the balance sheets of both entities and reflect the stockholders' equity/deficit as if the transaction had occurred at the date of the pro forma statements.

3